The White House, “The Precision Medicine Initiative, available at <https://obamawhitehouse.archives.gov/precision-medicine> (last visited March 6, 2020).+(last+visited+March+6,+2020).>Google Scholar

Electronic Medical Records and Genomics (eMerge) Network, available at <https://www.genome.gov/Funded-Programs-Projects/Electronic-Medical-Records-and-Genomics-Network-eMERGE> (last visited March 6, 2020).+(last+visited+March+6,+2020).>Google Scholar

Angrist, M., “Eyes Wide Open: The Personal Genome Project, Citizen Science and Veracity in Informed Consent,” Personalized Medicine 6, no. 6 (2009): 691-699.CrossRefGoogle Scholar

Woolley, J. et al., “Citizen Science or Scientific Citizenship? Disentangling the Uses of Public Engagement Rhetoric in National Research Initiatives,” BMC Medical Ethics 17 (2016): 33; Rothstein, M.A., “Ethical Issues in Big Data Health Research,” Journal of Law, Medicine & Ethics 43, no. 2 (2015): 425-429.CrossRefGoogle Scholar

Wiggins, A. and Wilbanks, J., “The Rise of Citizen Science in Health and Biomedical Research,” American Journal of Bioethics 19, no. 8 (2019): 3-14. See also Guerrini, C.J. et al., “Biomedical Citizen Science or Something Else? Reflections on Terms and Definitions,” American Journal of Bioethics 19, no. 8 (2019): 17-19; Riesch, H. and Potter, C., “Citizen Science as Seen by Scientists: Methodological, Epistemological and Ethical Dimensions,” Public Understanding of Science 23, no. 1 (2013): 107-120.CrossRefGoogle Scholar

Hoffman, S., “Citizen Science: The Law and Ethics of Public Access to Medical Big Data,” Berkeley Technology Law Journal 30, no. 3 (2015): 1741-1805; Khatib, F. et al., “Algorithm Discovery by Protein Folding Game Players,” Proceedings of the National Academy of Science 108, no. 47 (2011): 18949-18953; Irwin, A., “Science, Public Engagement,” In: Wright, J.D., ed., International Encyclopedia of the Social and Behavioral Sciences (Oxford: Elsevier, 2015): 255-260; McGowan, M. et al., “‘Let’s Pull These Technologies Out of the Ivory Tower’: The Politics, Ethos, and Ironies of Participant-driven Genomic Research,” BioSocieties 12, no. 4 (2017): 494-519.Google Scholar

Evans, B.J., “Parsing the Line between Professional and Citizen Science,” American Journal of Bioethics 19, no. 8 (2019): 15-17; Fiske, A., Prainsack, B., and Buyx, A., “Meeting the Needs of Underserved Populations: Setting the Agenda for More Inclusive Citizen Science of Medicine,” Journal of Medical Ethics 45, no. 9 (2019): 617-622.CrossRefGoogle Scholar

See Rothstein, M.A., Wilbanks, J.T., and Brothers, K.B., “Citizen Science on Your Smartphone: An ELSI Research Agenda,” Journal of Law, Medicine & Ethics 43, no. 4 (2015): 897-903.CrossRefGoogle Scholar

See, e.g., Berkelman, J., Li, Y., and Gross, C.P., “Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review,” Journal of the American Medical Association 289, no. 4 (2003): 454-465; Trouiller, P. et al., “Drug Development for Neglected Diseases: A Deficient Market and a Public-Health Policy Failure,” The Lancet 359, no. 9324 (2002): 2188-2194; Walsh, M., Grant, G., and Coleman, Z., “Action Research — A Necessary Complement to Traditional Health Science?” Health Care Analysis 16, no. 2 (2008): 127-144.CrossRefGoogle Scholar

See Wiggins and Wilbanks, supra note 5; Swan, M., “Crowd-sourced Health Research Studies: An Important Emerging Complement to Clinical Trials in the Public Health Ecosystem,” Journal of Medical Internet Research 14, no. 2 (2012): e46.CrossRefGoogle Scholar

See, e.g., Beresford, P., “Developing the Theoretical Basis for a Service User/Survivor-Led Research and Equal Involvement in Research,” Epidemiology and Psychiatric Services 14, no. 1 (2005): 4-9; Seyfried, G., Pei, L., and Schmidt, M., “European Do-It-Yourself (DIY) Biology: Beyond the Hope, Hype and Horror,” BioEssays 36, no. 6 (2014): 548-551.CrossRefGoogle Scholar

John T. Wilbanks, Co-PI on the grant reported in this article and co-author of this article, is the Chief Commons Officer of Sage Bionetworks.Google Scholar

McGowan et al., supra note 6.Google Scholar

Id.; Resnik, D.B., “Citizen Scientists as Human Subjects: Ethical Issues,” Citizen Science: Theory and Practice 4, no. 1 (2019): 1-7.Google Scholar

45 U.S.C. § 3724. See Helping Federal Agencies Accelerate Innovation through Public Participation, available at <https://www.citizenscience.gov/#> (last visited March 6, 2020).+(last+visited+March+6,+2020).>Google Scholar

Pub. L. 114-255 (2016).Google Scholar

Section 3022 of the 21st Century Cures Act provides that real world evidence may be based on “ongoing safety surveillance, observational studies, registries, claims, and patient-centered outcomes research activities.” See Sherman, R.E. et al., “Real World Evidence — What Is It and What Can It Tell Us?” New England Journal of Medicine 375, no. 23 (2016): 2293-2297.CrossRefGoogle Scholar

For a discussion of the study’s methodology, see Roth-stein, M.A. and Wilbanks, J.T., “Unregulated Health Research Using Mobile Devices: Introduction,” Journal of Law, Medicine & Ethics 48, no. 1, Suppl. (2020): 7-8.Google Scholar

See Parts I-B and III-B infra.Google Scholar

See Doerr, M. and Guerrini, C., “Who Are the People in Your Neighborhood? Personas Populating Unregulated mHealth Research,” Journal of Law, Medicine & Ethics 48, no. 1, Suppl. (2020): 37-48.CrossRefGoogle Scholar

The 16 Common Rule Departments and Agencies and their regulations are as follows: Department of Homeland Security, 6 C.F.R. Pt. 46; Department of Agriculture, 7 C.F.R. Pt. 1c; Department of Energy, 10 C.F.R. Pt. 745; National Aeronautics and Space Administration, 14 C.F.R. Pt. 1230; Department of Commerce, 15 C.F.R. Pt. 27; Social Security Administration, 20 C.F.R. Pt. 431; Agency for International Development, 22 C.F.R. Pt. 225; Department of Housing and Urban Development, 24 C.F.R. Pt. 60; Department of Labor, 29 C.F.R. Pt. 21; Department of Defense, 32 C.F.R. Pt. 219; Department of Education, 34 C.F.R. Pt. 97; Department of Veterans Affairs, 38 C.F.R. Pt. 16; Environmental Protection Agency, 40 C.F.R. Pt. 26; Department of Health and Human Services, 45 C.F.R. Pt. 46; National Science Foundation, 45 C.F.R. Pt. 690; Department of Transportation, 49 C.F.R. Pt. 11. The Department of Justice and the Consumer Product Safety Commission intend to be signatories to the 2018 Common Rule, and the Central Intelligence Agency and the Office of the Director of National Intelligence follow the Common Rule pursuant to Executive Orders. For a further discussion, see Meyer, M.N., “There Oughta Be a Law: When Does(n’t) the U.S. Common Rule Apply?” Journal of Law, Medicine & Ethics 48, no. 1, Supp. (2020): 60-73.CrossRefGoogle Scholar

Food and Drug Administration, Protection of Human Subjects, 21 C.F.R. Pt. 50.Google Scholar

Section 5(a) of the Federal Trade Commission Act, 15 U.S.C. § 45, prohibits “unfair or deceptive acts or practices in or affecting commerce.”Google Scholar

Pub. L. 104-191 (1996); 45 C.F.R. Pts. 160, 164.Google Scholar

Pub. L. 111-5 (2009); 74 Fed. Reg. 56123-56131.Google Scholar

See Part III-C infra.Google Scholar

45 C.F.R. § 46.102(l) (Department of Health and Human Services). In some cases, mobile health blurs the lines between research and other activities, such as product development, marketing, and quality improvement.Google Scholar

45 C.F.R. § 46.102(e) (Department of Health and Human Services).Google Scholar

For examples of various types of unregulated researchers, see Doerr and Guerrini, supra note 20. For use cases of unregulated research using mobile devices, see infra section I-D.Google Scholar

Dickinson, J.L., Zuckerberg, B., and Bonter, D.N., “Citizen Science as an Ecological Research Tool: Challenges and Benefits,” Annual Review of Ecology, Evolution, and Systematics 41, no. 1 (2010): 149-172.CrossRefGoogle Scholar

Kreitmair, K.V. and Magnus, D.C., “Citizen Science and Gamification,” Hastings Center Report 49, no. 2 (2019): 40-46.CrossRefGoogle Scholar

See Pauwels, E. and Denton, S.W., The Rise of the Bio-Citizen, Kuiken, T., ed. (2018): at 47-57, available at <https://www.wilsoncenter.org/sites/default/files/rise_of_biocitizenfinal.pdf> (last visited September 13, 2019).+(last+visited+September+13,+2019).>Google Scholar

Pew Research Center, “Global Attitudes Project, Smartphone Ownership Is Growing Around the World, But Not Always Equally,” February 5, 2019, available at <https://www.pewre-search.org/global/2019/02/05/smartphone-ownership-is-growing-rapidly-around-the-world-but-not-always-equally> (last visited March 6, 2020). See generally Sim, I., “Mobile Devices and Health,” New England Journal of Medicine 381, no. 10 (2019): 956-968.CrossRefGoogle Scholar

Edwards, A., “Health: Health Care Mobile App Trends in 2019,” Ortholive Blog, February 2, 2019, available at <www.ortholive.com/blog/ealth-healthcare-mobile-app-trends-in-2019> (last visited September 1, 2019).+(last+visited+September+1,+2019).>Google Scholar

Pohl, M., “325,000 Mobile Health Apps Available in 2017 — Android Now the Leading Mobile Health Platform,” Research 2 Guidance, 2017, available at <https://research2guidance.com/325000-mobile-health-apps-available-in-2017> (last visited March 6, 2020). For a discussion of the privacy risks created by many of the health apps, see Andrews, L., “A New Privacy Paradigm in the Age of Apps,” Wake Forest Law Review 53, no. 3 (2018): 421-478.Google Scholar

Nebeker, C., “mHealth Research Applied to Regulated and Unregulated Behavioral Health Sciences,” Journal of Law, Medicine & Ethics 48, no. 1, Suppl. (2020): 49-59.CrossRefGoogle Scholar

Chu, Z. and Majumdar, M., “Why Apple’s ResearchKit Signals a Golden Age for Health Care,” Fortune, March 27, 2015, available at <https://fortune.com/2015/03/27/why-apples-researchkit-signals-a-golden-age-for-health-care/> (last visited March 6, 2020).+(last+visited+March+6,+2020).>Google Scholar

Duhaime-Ross, A., “Apple’s New ResearchKit: ‘Ethics Quagmire’ or Medical Research Aid?” The Verge, March 10, 2015, available at <https://www.theverge.com/2015/3/10/8177683/apple-research-kit-app-ethics-medical-research> (last visited March 6, 2020).+(last+visited+March+6,+2020).>Google Scholar

Tourraine, V., “List of All ResearchKit Apps (from Science, February 1, 2016),” available at <http://blog.shazino.com/articles/science/researchkit-list-apps/> (last visited March 6, 2020).+(last+visited+March+6,+2020).>Google Scholar

Moore, S. et al., “Consent Processes for Mobile App Mediated Research: Systematic Review,” JMIR Mobile Health uHealth 5, no. 8 (2017):Google Scholar

Naughton, J., “‘The Goal Is to Automate Us’: Welcome to the Age of Surveillance Capitalism,” The Guardian, January 20, 2019, available at <https://www.theguardian.com/technology/2019/jan/20/shoshana-zuboff-age-of-surveillance-capitalism-google-facebook> (last visited March 6, 2020).+(last+visited+March+6,+2020).>Google Scholar

Gray, C.M. et al., “The Dark (Patterns) Side of UX Design,” in Proceedings of the 2018 CHI Conference on Human Factors in Computing Systems (CHI ‘18) (New York, N.Y., ACM, 2018).Google Scholar

Obar, J. and Oeldorf-Hirsch, A., “The Biggest Lie on the Internet: Ignoring the Privacy Policies and Terms of Service Policies of Social Networking Services,” June 1, 2018, from TPRC 44: The 44th Research Conference on Communication, Information and Internet Policy, 2016, available at <https://ssrn.com/abstract=2757465> (last visited March 6, 2020).+(last+visited+March+6,+2020).>Google Scholar

Litman-Navarro, K., “We Read 150 Privacy Policies. They Were an Incomprehensible Disaster,” New York Times, June 12, 2019, available at <https://www.nytimes.com/interactive/2019/06/12/opinion/facebook-google-privacy-policies.html> (last visited March 6, 2020).+(last+visited+March+6,+2020).>Google Scholar

See McDonald, A.M. and Cranor, L.F., “The Cost of Reading Privacy Policies,” I/S: A Journal of Law and Policy for the Information Society, 2008 Privacy Year in Review (noting the burden of reading privacy policies).Google Scholar

Statcounter, Mobile Operating System Market Share, United States of America, May 2018-May 2019, available at <http://gs.statcounter.com/os-market-share/mobile/united-states-of-america> (last visited March 6, 2020).+(last+visited+March+6,+2020).>Google Scholar

Vaidhyanathan, S., The Googlization of Everything: (and Why We Should Worry) (Berkeley: University of California Press, 2012).CrossRefGoogle Scholar

Jorgensen, T.B., “Will ‘Sign in with Apple’ Revolutionize Digital Identity?” Infosecurity Magazine, July 11, 2019, available at <https://www.infosecurity-magazine.com/opinions/sign-apple-digital-identity-1-1/> (last visited March 6, 2020).+(last+visited+March+6,+2020).>Google Scholar

Fowler, G.A., “Review: Google Chrome Has Become Surveillance Software: It’s Time to Switch,” Mercury News, June 21, 2019, available at <https://www.mercurynews.com/2019/06/21/google-chrome-has-become-surveillance-software-its-time-to-switch/> (last visited March 6, 2020).+(last+visited+March+6,+2020).>Google Scholar

One way in which this difference is evident is in their approach to pornography. See “Apple CEO Cook: We Don’t Want Porn in Our App Store,” MacDaily News, March 29, 2018, available at <https://macdailynews.com/2018/03/29/apple-ceo-cook-we-dont-want-porn-in-our-app-store/> (last visited March 6, 2020).+(last+visited+March+6,+2020).>Google Scholar

Terry, K., “Apple Opens iPhone EHR Feature to All Health Care Organizations,” Medscape, July 3, 2019, available at <https://www.medscape.com/viewarticle/915208> (last visited March 9, 2020).+(last+visited+March+9,+2020).>Google Scholar

Carin Alliance, The Carin Alliance Code of Conduct, available at <https://www.carinalliance.com/our-work/trust-framework-and-code-of-conduct/> (last visited March 9, 2020).+(last+visited+March+9,+2020).>Google Scholar

These issues are further discussed in section II-C infra and Brothers, K.B., Clayton, E.W., and Goldenberg, A.J., “Online Pediatric Research: Addressing Consent, Assent, and Parental Permission,” Journal of Law, Medicine & Ethics 48, no 1, Suppl. (2020): 129-137.CrossRefGoogle Scholar

Wolf, S.M., “Return of Results in Unregulated Research Using Mobile Devices,” Journal of Law, Medicine & Ethics 48, no. 1, Suppl. (2020): 159-166.CrossRefGoogle Scholar

See Bonney, R. et al., “Next Steps for Citizen Science,” Science 343, no. 6178 (2014): 1427-1436; Fiske, A. et al., “Conceptual and Ethical Considerations for Citizen Science in Biomedicine,” Heyen, N.B., Dickel, S., and Brüninghaus, A., eds., Personal Health Science (Wiesbaden: Springer 2018): at 195-217.CrossRefGoogle Scholar

Emanuel, E.J., Wendler, D., and Grady, C., “What Makes Clinical Research Ethical?” Journal of the American Medical Association 283, no. 20 (2000): 2701-2711; Hood, L. and Flores, M., “A Personal View on Systems Medicine and the Emergence of Proactive P4 Medicine: Predictive, Preventive, Personalized and Participatory,” Nature Biotechnology 29 (2012): 613-624.CrossRefGoogle Scholar

See Risk of Harms, infra Part I-F.Google Scholar

Largent, E.A., Lynch, H.F., and McCoy, M.S., “Patient-Engaged Research: Choosing the “Right” Patients to Avoid Pitfalls,” Hastings Center Report 48, no. 5 (2018): 26-34.CrossRefGoogle Scholar

Janssens, A.C. and Kraft, P., “Research Conducted Using Data Obtained through Online Communities: Ethical Implications of Methodological Limitations,” Public Library of Science: Medicine (2012): e1001328.CrossRefGoogle Scholar

Del Savio, L., Prainsack, B., and Buyx, B., “Motivations of Participants in the Citizen Science of Microbiomics: Data from the British Gut Project,” Genetics in Medicine 19, no. 8 (2017): 959-961. See also Callier, S. and Fullerton, S.M., “Diversity and Inclusion in Unregulated mHealth Research: Addressing the Risks,” Journal of Law, Medicine & Ethics 48, no. 1, Suppl. (2020): 115-121; Fiske et al., supra note 55.CrossRefGoogle Scholar

Vayena, E. and Tasioulas, J., “Adapting Standards: Ethical Oversight of Participant-Led Research,” Public Library of Science: Medicine (2013).CrossRefGoogle Scholar

Resnik, D., “Citizen Scientists as Human Subjects: Ethical Issues,” 2019, available at <https://theoryandpractice.citizen-scienceassociation.org/articles/10.5334/cstp.150/print/> (last visited March 8, 2020).CrossRef+(last+visited+March+8,+2020).>Google Scholar

Riesch, H. and Potter, C., “Citizen Science as Seen by Scientists: Methodological, Epistemological and Ethical Dimensions,” Public Understanding of Science 23, no. 1 (2013): 107-120, at 111.CrossRefGoogle Scholar

An area of increasing concern is the compelled use of wearable devices by employers and insurers to measure compliance and effects of fitness tracking devices.Google Scholar

See Yu, J.H. and Juengst, E., “Do Groups Have Moral Standing in Unregulated mHealth Research?” Journal of Law, Medicine & Ethics 48, no. 1, Supp. (2020): 122-128.CrossRefGoogle Scholar

Feraro, N.A., Morrell, D.S., and Burkhart, C.N., “Skin Scan: A Demonstration of the Need for FDA Regulation of Medical Apps on iPhone,” Journal of the American Academy of Dermatology 68, no. 3 (2013): 515-516.CrossRefGoogle Scholar

Huckvale, K. et al., “Smartphone Apps for Calculating Insulin Dose: A Systematic Assessment,” BMC Medicine 13 (2015): 106.CrossRefGoogle Scholar

U.S. Food and Drug Administration, “FDA Warns against the Use of Unauthorized Devices for Diabetes Management,” May 17, 2019, available at <https://www.fda.gov/news-events/press-announcements/fda-warns-against-use-unauthorized-devices-diabetes-management> (last visited March 9, 2020).+(last+visited+March+9,+2020).>Google Scholar

Baron, K.G. et al., “Are Some Patients Taking the Quantified Self Too Far?” Journal of Clinical Sleep Medicine 13, no. 2 (2017): 351-354; Chen, B.X., “Data that May Keep You Up at Night: Sleep-tracking Apps and Devices Can’t Cure Your Insomnia, and They Could Even Make It Worse,” New York Times, July 18, 2019, at B6.CrossRefGoogle Scholar

Turner, P.G. and Lefevre, C.E., “Instagram Use Is Linked to Increased Symptoms of Orthorexia Nervosa,” Eating and Weight Loss Disorders 22, no. 2 (2017): 277-284.CrossRefGoogle Scholar

Simpson, C.C. and Mazzeo, S.E., “Calorie Counting and Fitness Tracking Technology: Associations with Eating Disorder Symptomatology,” Eating Behaviors 26, no. 1 (2017): 89-92.CrossRefGoogle Scholar

See, e.g., Wakefield, J., “Sex Lives of App Users ‘Shared with Facebook,’” available at <https://www.bbc.com/news/technology-49647239> (last visited March 9, 2020) (fertility/menstrual tracking apps shared data about sexual activity with Facebook).+(last+visited+March+9,+2020)+(fertility/menstrual+tracking+apps+shared+data+about+sexual+activity+with+Facebook).>Google Scholar

Huckvale, K., Torous, J., and Larsen, M.E., “Assessment of Data Sharing and Privacy Practices of Smartphone Apps for Depression and Smoking Cessation,” JAMA Network Open 2, no. 4 (2019): e192542.CrossRefGoogle Scholar

Blenner, S.R. et al., “Privacy Policies of Android Diabetes Apps and Sharing of Health Information,” Journal of the American Medical Association 315, no. 10 (2016): 1051-1052.Google Scholar

Smith, D.G., “Mental Health Apps Are Scooping Up Your Most Sensitive Data. Will You Benefit?” STAT, September 20, 2019, available at <https://www.statnews.com/2019/09/20/mental-health-apps-capture-sensitive-data> (last visited September 20, 2019).+(last+visited+September+20,+2019).>Google Scholar

Id.Google Scholar

McDonald, A., McDonnell, J., and Mitchell, C., “Mobile Apps: Redefining the Virtual California Economy and the Laws that Govern It,” Competition: Journal of the Antitrust and Unfair Competition Law Section of the State Bar of California 24, no. 2 (2015): 86, 88.Google Scholar

Schaffer, P., “Data Breaches on the Rise: How Healthcare Organizations Can Protect against Medical Identity Theft,” Digital Health News, July 3, 2018, available at https://www.idigital-health.com/news/data-breaches-on-the-rise-how-healthcare-organizations-can-protect-against-medical-identity-theft.Google Scholar

Dongjing, H. et al., “Security Concerns in Android Mobile Health Apps,” AMIA Annual Symposium Proceedings 2014 (2014): 645-654.Google Scholar

Janssens, A.C. and Kraft, P., “Research Conducted Using Data Obtained through Online Communities: Ethical Implications of Methodological Limitations, Public Library of Science: Medicine (2012): 9, e1001328. See generally Fiske, A. et al., “Conceptual and Ethical Considerations for Citizen Science in Biomedicine,” in Heyen, N.B., Dickel, S., and Bruninghaus, A., eds., Personal Health Science (Wiesbaden, Germany: Springer 2018): at 195-217.Google Scholar

See Majumder, M.A. and McGuire, A.L., “Data Sharing in the Context of Health-Related Citizen Science,” Journal of Law, Medicine & Ethics 48, no. 1, Suppl. (2020): 167-177.CrossRefGoogle Scholar

Of course, even regulated research is subject to misleading characterization and dissemination on the internet.Google Scholar

Armstrong, P.W. and Naylor, C.D., “Counteracting Health (Mis) information: A Role for Medical Journals?” Journal of the American Medical Association 321, no. 19 (2019): 1863-1864; Kata, A., “Anti-vaccine Activists, Web 2.0, and the Postmodern Paradigm — An Overview of Tactics and Tropes Used Online by the Anti-vaccination Movement,” Vaccine 30, no. 25 (2012): 3778-3789.CrossRefGoogle Scholar

Hauser, C., “Whatever Ails You, F.D.A. Says, Drinking Bleach Isn’t the Answer,” New York Times, August 14, 2019, at A19: Zadrozny, B., “Fake Science Led a Mom to Feed Bleach to Her Autistic Sons — and Police Did Nothing to Stop Her,” NBS News Internet, June 14, 2019, available at <https://www.nbc-news.com/tech/internet/fake-science-led-mom-fee-bleach-her-autistic-sons-police-n1017256> (last visited March 9, 2020).Google Scholar

Department of Health and Human Services, Office for Human Research Protections, International Compilations of Human Research Standards (2019 ed.), available at <https://www.hhs.gov/ohrp/sites/default/files/2019-International-Compilation-of-Human-Research-Standards.pdf> (last visited March 9, 2020) (Canada, Finland, France, and many other countries regulate all research without regard to funding source).+(last+visited+March+9,+2020)+(Canada,+Finland,+France,+and+many+other+countries+regulate+all+research+without+regard+to+funding+source).>Google Scholar

See Rasmussen, L.M., Filling the ‘Ethics Gap’ in Citizen Science Research: A Workshop Report (2016), available at <https://www.niehs.nih.gov/research/supported/translational/peph/webinars/ethics/rasmussen_508.pdf> (last visited March 9, 2020).+(last+visited+March+9,+2020).>Google Scholar

Unregulated research also raises a wide range of issues normally referred to as “scientific integrity,” including research misconduct, conflicts of interest, sharing data and samples, assigning authorship, and acting in a socially responsible manner. See Resnik, D.B., “Citizen Scientists as Human Subjects: Ethical Issues,” available at <https://theoryandpractice.citizenscienceassociation.org/articles/10.5334/cstp.150/print> (last visited March 9, 2020). These issues are beyond the scope of this research project.+(last+visited+March+9,+2020).+These+issues+are+beyond+the+scope+of+this+research+project.>Google Scholar

National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research (Washington, D.C.: U.S. Gov’t Printing Office, 1979): section B-2.Google Scholar

King, N.M., “Defining and Describing Benefit Appropriately in Clinical Trials,” Journal of Law, Medicine & Ethics 28, no. 2 (2000): 332-343.CrossRefGoogle Scholar

Miller, P.B. and Weijer, C., “Rehabilitating Equipoise,” Kennedy Institute of Ethics Journal 13, no. 2 (2003): 93-118.CrossRefGoogle Scholar

Nickerson, R.S., “Confirmation Bias: A Ubiquitous Phenomenon in Many Guises,” Review of General Psychology 2, no. 2 (1998): 175-220.CrossRefGoogle Scholar

Belmont Report, supra note 88.Google Scholar

45 C.F.R. § 46.116.Google Scholar

Albala, I., Doyle, M., and Appelbaum, P.S., “The Evolution of Consent Forms for Research: A Quarter Century of Changes,” IRB 32, no. 3 (2010): 7-11; Paasche-Orlow, M.K. et al., “Readability of Consent Form Templates: A Second Look,” IRB 35, no. 4 (2013): 12-19; Larson, E., Foe, G., and Lally, R., “Reading Level and Length of Written Research Consent Forms,” Clinical and Translational Science 8, no. 4 (2015): 355-356.Google Scholar

Montalvo, W. and Larson, E., “Participant Comprehension of Research for Which They Volunteer: A Systematic Review,” Journal of Nursing Scholarship 46, no. 6 (2014): 423-431.CrossRefGoogle Scholar

Id.; Nishimura, A. et al., “Improving Understanding in the Research Informed Consent Process: A Systematic Review of 54 Interventions Tested in Randomized Control Trials,” BMC Medical Ethics 14 (2018): 28; Tamariz, L. et al., “Improving the Informed Consent Process for Research Subjects with Low Literacy: A Systematic Review,” Journal of General Internal Medicine 28, no. 1 (2013): 121-126.CrossRefGoogle Scholar

Hammack-Aviran, C.M., Brelsford, K.M., and Beskow, L.M., “Ethical Considerations in the Conduct of Unregulated Mobile Health Research,” Journal of Law, Medicine & Ethics 48, no. 1, Suppl. (2020): 9-36.CrossRefGoogle Scholar

Id.Google Scholar

Garrison, N.A. et al., A Systematic Literature Review of Individuals’ Perspectives on Broad Consent and Data Sharing in the United States,” Genetics in Medicine 18, no. 7 (2016): 663-671; Steinsbekk, K.S., Myskja, B., and Solberg, B., “Broad Consent Versus Dynamic Consent in Biobank Research: Is Passive Participation an Ethical Problem?” European Journal of Human Genetics 21, no. 9 (2013): 897-902.CrossRefGoogle Scholar

Ridpath, J.R., Greene, S.M., and Wiese, C.J., “PRISM Readability Toolkit — 2007,” available at <https://www.kpwashington-research.org/about-us/capabilities/research-communications/prism/> (last visited March 9, 2020).+(last+visited+March+9,+2020).>Google Scholar

Agency for Health Research and Quality, Informed Consent, available at <https://www.ahrq.gov/funding/policies/informedconsent/index.html> (last visited March 9, 2020).+(last+visited+March+9,+2020).>Google Scholar

Hammack-Aviran, Brelsford, and Beskow, supra note 97.Google Scholar

Sage Bionetworks, Toolkits for Informed Consent, and Mobile Research Studies, available at <https://sagebionetworks.org/tools_resources/elements-of-informed-consent/>; <https://sagebionetworks.org/tools_resources/privacy-toolkit-for-mobile-health-research-studies/> (both last visited March 9, 2020).;++(both+last+visited+March+9,+2020).>Google Scholar

Doerr, M. et al., “Formative Evaluation of Participant Experience with Mobile eConsent in the App-Mediated Parkinson mPower Study: A Mixed Methods Study,” Journal of Medical Informatics Research Mobile Health Uhealth 5, no. 2 (2017): e14.Google Scholar

Wilbanks, J., “Electronic Informed Consent in Mobile Applications Research,” Journal of Law, Medicine & Ethics 48, no. 1, Supp. (2020): 147-153. See also Cummings, S.R. and Rowbotham, M.C., “Electronic Informed Consent and Internet-Based Trials,” New England Journal of Medicine 376, no. 9 (2017): 859-861; McConnell, M.V. and Ashley, E.A., “Mobile Health Research — App-Based Trials and Informed Consent,” New England Journal of Medicine 376, no. 9 (2017): 861-863.CrossRefGoogle Scholar

World Medical Association, Declaration of Helsinki, General Principles, ¶9 (1964).Google Scholar

Id., Preamble, ¶2.Google Scholar

Id.Google Scholar

Council for International Organizations of Medical Sciences, International Ethical Guidelines for Health-Related Research Involving Humans, Guideline 22 (4th ed. 2016) (“Use of Data Obtained from the Online Environment and Digital Tools in Health-Related Research”).Google Scholar

Id.Google Scholar

Id.Google Scholar

Id.Google Scholar

45 C.F.R. § 46.111(a)(7).Google Scholar

See id. § 160.103 (defining covered entity to include a health plan, a health care clearinghouse, and a health care provider that transmits any health information in electronic form in connection with a standard transaction); U.S. Department of Health and Human Services, Protecting Personal Health Information in Research: Understanding the HIPAA Privacy Rule (2003): 1-37 (“In some instances, researchers may have to comply with the Privacy Rule because they may be or may work for a covered entity. For example, the Privacy Rule defines covered entities to include health care providers that transmit health information electronically in connection with certain financial and administrative transactions (such as most hospitals). As such, researchers who are or who work for these covered entities would need to understand the Privacy Rule…”).Google Scholar

45 C.F.R. §§ 164.502-.514.Google Scholar

Id. §§ 164.520-.528.Google Scholar

Id. § 164.530.Google Scholar

Id. § 164.508(a)(1) (establishing the prior written authorization requirement); id. § 164.512(i)(1)(i)-(iii) (establishing three research-related exceptions to the authorization requirement); id. § 164.514(e) (establishing a fourth research-related exception to the authorization requirement for limited research data sets). Some state laws also impose privacy and security obligations on certain researchers. For example, Texas law requires researchers not regulated by the HIPAA Privacy Rule to provide notice and obtain authorization before electronically disclosing an individual’s PHI, refrain from using or disclosing an individual’s PHI for certain marketing activities unless the individual gives “clear and unambiguous” written or electronic permission, refrain from disclosing an individual’s PH in exchange for direct or indirect remuneration and complete privacy training. Tex. Health & Safety Code §§ 181. 101,. 152-154.Google Scholar

Id. § 164.308.Google Scholar

Id. § 164.310.Google Scholar

Id. § 164.312.Google Scholar

Id. § 164.306(a)(1)-(2).Google Scholar

Id. §§ 164.400-.414.Google Scholar

45 C.F.R. Part 46B (pregnant women, human fetuses and neonates involved in research); 45 C.F.R. Part 46C (prisoners); 45 C.F.R. Part 46D (children). National Institutes of Health, Vulnerable and Other Populations Requiring Additional Protection, available at <https://grants.nih.gov/policy/humansubjects/policies-and-regulations/vulnerable-populations.htm> (last visited March 9, 2020).+(last+visited+March+9,+2020).>Google Scholar

See Coleman, C.H., “Vulnerability as a Regulatory Category in Human Subject Research,” Journal of Law, Medicine & Ethics 37, no. 1 (2009): 12-18; Metcalf, J. and Crawford, K., “Where Are Human Subjects in Big Data Research? The Emerging Ethics Divide,” Big Data & Society (2016): 1-4.CrossRefGoogle Scholar

Council for International Organizations of Medical Sciences, International Ethical Guidelines for Health-Related Research Involving Humans, Guideline 22, 4th ed. (2016) (“Use of Data Obtained from the Online Environment and Digital Tools in Health-Related Research”).Google Scholar

Brothers, Clayton, and Goldenberg, supra note 53.Google Scholar

Anderson, M., “Racial and Ethnic Differences in How People Use Mobile Technology,” Pew Research Center (2015), available at <https://www.pewresearch.org/fact-tank/2015/04/30/racial-and-ethnic-differences-in-how-people-use-mobile-technology> (last visited March 9, 2020); Sylvain, O., “Network Equality,” Hastings Law Journal 67, no. 3 (2015): 443-497. On the issue of group harms, see Yu and Juengst, supra note 65.Google Scholar

Montgomery, K., Chester, J., and Kopp, K., “Health Wearable Devices in the Big Data Era: Ensuring Privacy, Security, and Consumer Protection,” Center for Digital Democracy Report (2016), available at <https://www.democraticmedia.org/sites/default/files/field/public/2016/aucdd_wearables-report_final121516.pdf> (last visited March 9, 2020); Senders, J.T. et al., “The Ethics of Passive Data and Digital Phenotyping in Neurosurgery,” in Broekman, M.L.D. ed., Ethics of Innovation in Neurosurgery (Switzerland: Springer, 2019): at 129-141.Google Scholar

Reyes, R. et al., “Where Is the Community Dimension in the Updated Common Rule?” Progress in Community Health Partnerships: Research, Education, and Action 12, no. 1 (2018): 83-87.CrossRefGoogle Scholar

World Medical Association, Declaration of Helsinki — Ethical Principles for Medical Research Involving Human Subjects, available at <https://www/wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects> (last visited March 9, 2020).+(last+visited+March+9,+2020).>Google Scholar

Grady, C., “Institutional Review Boards: Purposes and Challenges, Chest 148, no. 5 (2015): 1148-1155.CrossRefGoogle Scholar

45 C.F.R. § 46.111.Google Scholar

Forster, D., “Independent Institutional Review Boards,” Seton Hall Law Review 32, no. 3 (2003): 513-523.Google Scholar

Beskow, L.M. et al., “Expert Perspectives on Oversight for Unregulated Mobile Health Research: Empirical Data and Commentary,” Journal of Law, Medicine & Ethics 48, no. 1, Suppl. (2020): 138-146.CrossRefGoogle Scholar

Emanuel, E.J., Wendler, D., and Grady, C., “What Makes Clinical Research Ethical?” Journal of the American Medical Association 283, no. 20 (2000): 2701-2711.CrossRefGoogle Scholar

See Friesen, P., Redman, B., and Caplan, A., “Of Straws, Camels, Research Regulations, and IRBs,” Therapeutic Innovation & Regulatory Science 53, no. 4 (2019).CrossRefGoogle Scholar

Emanuel, E.J. et al., “Oversight of Human Participants Research: Identifying Problems to Evaluate Reform Proposals,” Annals of Internal Medicine 141, no. 4 (2004): 282-291.CrossRefGoogle Scholar

Nebeker, C. et al., “Ethical and Regulatory Challenges of Research Using Pervasive Sensing and Other Emerging Technologies,” American Journal of Bioethics Empirical Bioethics 8, no. 4 (2017): 266-276.CrossRefGoogle Scholar

Beskow et al., supra note 135.Google Scholar

National Research Council, “Guiding Principles for Scientific Inquiry,” in Scientific Research in Education (Washington, D.C.: The National Academies Press, 2002): at 50-79.Google Scholar

Nicholls, S.G. et al., “Reporting Transparency: Making the Ethical Mandate Explicit,” BMC Medicine [Internet] 14, no. 1 (2016): 44, available at <https://doi.org/10.1186/s12916-016-0587-5> (last visited March 9, 2020). See generally Shamoo, A.E. and Resnik, D.B., Responsible Conduct of Research, 4th ed. (New York: Oxford University Press, 2015).Google Scholar

Martinson, B.C., Anderson, M.S., and de Vries, R., “Scientists Behaving Badly,” Nature 435, no. 7043 (2005): 737-738.CrossRefGoogle Scholar

National Academies of Sciences, Engineering, and Medicine. Open Science by Design: Realizing a Vision for 21st Century Research (Washington, D.C.: The National Academies Press, 2018).Google Scholar

World Health Organization, Code of Conduct for Responsible Research 2017, available at <https://www.who.int/about/ethics/code-of-conduct-responsible-research.pdf> (last visited March 9, 2020).+(last+visited+March+9,+2020).>Google Scholar

Woods, B., Coravos, A., and Corman, J.D., “The Case for a Hippocratic Oath for Connected Medical Devices,” Journal of Medical Internet Research 21, no. 3 (2019): e12568.CrossRefGoogle Scholar

See, e.g., Newman, L.H., “A New Pacemaker Hack Puts Mal-ware Directly on the Device,” Wired, August 9, 2018, available at <https://www.wired.com/story/pacemaker-hack-malware-black-hat/> (last visited March 9, 2020).+(last+visited+March+9,+2020).>Google Scholar

Guiding Principles on Ethics in Digital Health Produced During a Seminar at Stanford Libraries, Feb. 21, 2019, available at <http://library.stanford.edu/node/156021> (last visited March 9, 2020).+(last+visited+March+9,+2020).>Google Scholar

Grant, A.D., Wolf, G.I., and Nebeker, C., “Approaches to Governance of Participant-led Research: A Qualitative Case Study,” British Medical Journal Open 9 (2019): e025633.Google Scholar

Lynn, S.J. et al., “Designing a Platform for Ethical Citizen Science: A Case Study of CitSci.org,” Citizen Science: Theory and Practice 4, no. 1 (2018); id. (Grant, Wolf, and Nebeker).Google Scholar

Grant, Wolf, and Nebeker, supra note 149.Google Scholar

Id., at 9.Google Scholar

Lynn et al., supra note 150.Google Scholar

Woolley, J.P. et al., “Citizen Science or Scientific Citizenship? Disentangling the Uses of Public Engagement Rhetoric in National Research Initiatives,” BMC Medical Ethics 17, no. 1 (2016): 33.CrossRefGoogle Scholar

Vayena and Tasioulas, supra note 61.Google Scholar

Id.Google Scholar

Id. A related source of ethical frameworks is the cybersecurity research community. The Hippocratic Oath for Connected Medical Devices “describes commitments to capabilities that preserve patient safety, as well as trust in the process of care delivery itself.” I Am the Cavalry, Hippocratic Oath for Connected Medical Devices, available at <https://iamthecavalry.org/oath> (last visited March 9, 2020). See Woods, B., Corvasos, A., and Corman, J.D., “The Case for a Hippocratic Oath for Connected Medical Devices: Viewpoint,” Journal of Medical Internet Research 21, no. 3 (2019), available at <http://www.jmir.org/2019/3/e/2568> (last visited March 9, 2020).CrossRefGoogle Scholar

Lang, M., Knoppers, B.M., and Zawati, M.H., “International mHealth Research: Old Tools and New Challenges,” Journal of Law, Medicine & Ethics 48, no. 1, Supp. (2020): 178-186; Dove, E.S. and Chen, J., “To What Extent Does the EU General Protection Regulation (GDPR) Apply to Citizen Scientist-Led Health Research with Mobile Devices? Journal of Law, Medicine & Ethics 48, no. 1, Supp. (2020): 187-195.CrossRefGoogle Scholar

See McGowan et al., supra note 6.Google Scholar

Department of Health and Human Services, Office for Human Research Protections, International Compilations of Human Research Standards (2019 ed.), available at <https://www.hhs.gov/ohrp/sites/default/files/2019-International-Compilation-of-Human-Research-Standards.pdf> (last visited March 11, 2020) (Canada, Finland, France, and many other countries regulate all research without regard to its source of funding).+(last+visited+March+11,+2020)+(Canada,+Finland,+France,+and+many+other+countries+regulate+all+research+without+regard+to+its+source+of+funding).>Google Scholar

Unregulated researchers, such as citizen scientists and patient-directed researchers, lack the expertise and resources of academic medical centers and other government-funded entities.Google Scholar

See § I-F, supra.Google Scholar

“[C]itizen scientists are human, and like past human researchers, may not see or be tempted to ignore ethical issues in their work that oversight by others might have helped to identify.” Rasmussen, L.M., “When Citizens Do Science: Stories from Labs, Garages, and Beyond,” Narrative Inquiry in Bioethics 9, no. 1 (2019): 1-4, at 2.CrossRefGoogle Scholar

Cf. Vayena and Tasioulas, supra note 61 (proposing a risk-based approach).Google Scholar

National Research Act, Pub. L. 93-348, 88 Stat. 342 (1974).Google Scholar

See generally Jones, J.H., Bad Blood: The Tuskegee Syphilis Experiment (New York: Free Press, expanded ed. 1993); Brandt, A.M., “Racism and Research: The Case of the Tuskegee Syphilis Experiment,” Hastings Center Report 8, no. 6 (1978): 21-29.Google Scholar

The National Research Act also established the National Commission for the Protection of Human Subjects in Biomedical and Behavioral Research. Its best known work was The Belmont Report, Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: Department of Health, Education, and Welfare; DHEW Publication OS 78-0012 (1978), available at <http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm> (last visited March 11, 2020).+(last+visited+March+11,+2020).>Google Scholar

See note 21 supra.Google Scholar

21 C.F.R. Pt. 50. See Food and Drug Administration, “Protection of Human Subjects; Informed Consent,” Federal Register 46 (1981): 8942.Google Scholar

These federal wide assurances (FWAs), remain permissible on a voluntary basis in the revised Common Rule. Department of Homeland Security et al., “Federal Policy for the Protection of Human Subjects: Final Rule,” Federal Register 82 (2017): 7149-7258, 7156.Google Scholar

Federman, D.D., Hanns, K.E., and Rodriguez, L.L., eds., Responsible Research: A Systems Approach to Protecting Research Participants (Washington, D.C.: National Academies Press, 1993).Google Scholar

National Bioethics Advisory Commission, Ethical and Policy Issues in Research Involving Human Participants (Bethesda, MD: 2001).Google Scholar

Department of Homeland Security et al., “Federal Policy for the Protection of Human Subjects: Final Rule,” Federal Register 82 (2017): 7149-7258.Google Scholar

Department of Homeland Security et al., “Federal Policy for the Protection of Human Subjects: Six Month Delay of the General Compliance Date of Revisions While Allowing the Use of Three Burden-Reducing Provisions During the Delay Period,” Federal Register 83 (2018): 28497.Google Scholar

Department of Health and Human Services, “Human Subjects Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators: Advance Notice of Proposed Rulemaking,” Federal Register 76 (2011): 44512.Google Scholar

Department of Homeland Security et al., “Federal Policy for the Protection of Human Subjects: Notice of Proposed Rule-making,” Federal Register 80 (2015): 53933-54061.Google Scholar

Id., at 53989-53992.Google Scholar

Upon reflection on the perspectives expressed by these commenters, we were persuaded that the proposed extension of the Common Rule is not appropriate to include in a final rule at this time.” Final Rule, supra note 164, at 7156.Google Scholar

It is not clear whether the Common Rule departments and agencies currently have the statutory authority to do so or whether new federal legislation would be necessary, which would base the constitutional authority on the Commerce Clause or other part of the Constitution, rather than the Spending Clause. See Meyer, M., “The Common Rule and Mobile Health Research,” Journal of Law, Medicine & Ethics 48, no. 1, Suppl. (2020): 60-73.CrossRefGoogle Scholar

See Tovino, S.A., “Going Rogue: Mobile Research Applications and the Right to Privacy,” Notre Dame Law Review 95, no. 1 (2019), available at <https://scholarship.law.nd.edu/ndlr/vol95/iss1/4> (last visited March 11, 2020) (surveying state research laws and state data privacy, security, and breach notification laws); Tovino, S.A., “Mobile Research Apps and State Data Protection Statutes,” Journal of Law, Medicine, & Ethics 48, no. 1, Supp. (2020): 87-93 (analyzing state research laws and state consumer privacy laws).Google Scholar

Md. Code Ann., Health-Gen. §§ 13-2001--13-2004.Google Scholar

Id. § 13-2002(b).Google Scholar

Id. § 13-2002(a).Google Scholar

Id. § 13-2002(a).Google Scholar

Id. § 13-2001(b)(1) (italicized emphasis added).CrossRefGoogle Scholar

See New State Ice Co. v. Liebmann, 285 U.S. 262, 311 (1932) (Brandeis, J., dissenting) (“It is one of the happy incidents of the federal system that a single courageous State may, if its citizens choose, serve as a laboratory; and try novel social and economic experiments without risk to the country.”).Google Scholar

Va. Code Ann. §§ 32.1-162.16—32.1-162.20.Google Scholar

Id. § 32.1-162.19(A).Google Scholar

Id. § 32.1-162.19(B).Google Scholar

Id. §§ 32.1-162.18(A), 32.1-162.19(B).Google Scholar

N.Y. Pub. Health §§ 2440-2446.Google Scholar

Id. § 2441(2).Google Scholar

Cal. Health & Safety Code §§ 24170-24179.5.Google Scholar

Id. § 24172.Google Scholar

Id. §§ 24173, 24175.Google Scholar

Id. § 24176.Google Scholar

Id.Google Scholar

77 Ill. Admin. Code § 250.130(b)(1)(B).Google Scholar

Wis. Stat. § 51.61(1)(a)(j).Google Scholar

Id. § 51.61(1).Google Scholar

Fla. Stat. Ann. § 381.026(4)(e).Google Scholar

Id. § 381.026(4)(e).Google Scholar

See Tovino, supra note 180 (surveying state data breach, security, and privacy statutes).Google Scholar

Id.Google Scholar

Id.Google Scholar

Id.Google Scholar

Id.Google Scholar

See, e.g., Ariz. Rev. Stat. § 20-448.02; Del. Code tit. 16, § 5175; Fla. Stat. § 760.40; Iowa Code § 729.6; Kan. Stat. § 65-4974; Mass. Gen. Laws § 70G; Mich. Comp. Laws §§ 333.17020, 333.17520; Miss. Code § 41-41-17; Neb. Rev. Stat. § 71-551; Nev. Rev. Stat. § 629.101 to .201; N.H. Rev. Stat. ch. 141-H:2; N.M. Sta. § 24-21-7; N.Y. Ins. Law § 2615; S.C. Code § 38-93-50.Google Scholar

See, e.g., Fla. Stat. § 760.40; Ill. Comp. Stat. ch. 410, § 1-50; Me. Stat. tit. 22, § 1711-C; N.J. Stat. § 10:15-43 to -49; Okla. Stat. § 3614.4; Or. Rev. Stat. § 192.547; R.I. Gen. Laws §§ 27-19-44.1, 27-20-39.1, 27-41-53.1; S.C. Code § 38-93-40; Tenn. Code § 56-7-2701.Google Scholar

See, e.g., Cal. Civ. Code § 56.17; Colo. Rev. Stat, § 10-3-1104.6; Or. Rev. Stat. §§ 192.537, -.539, -.581; Tex. Occ. Code § 56.17.Google Scholar

National Institutes of Health, Budget (2019), available at <https://www.nih.gov/about-nih/what-we-do/budget> (last visited March 11, 2020).+(last+visited+March+11,+2020).>Google Scholar

Id.Google Scholar

National Institutes of Health, “About the NIH Common Fund,” available at <https://commonfund.nih.gov/> (last visited March 11, 2020): “Common Fund programs address emerging scientific opportunities and pressing challenges in biomedical research that no single NIH Institute or Center (IC) can address on its own, but are of high priority for the NIH as a whole.”+(last+visited+March+11,+2020):+“Common+Fund+programs+address+emerging+scientific+opportunities+and+pressing+challenges+in+biomedical+research+that+no+single+NIH+Institute+or+Center+(IC)+can+address+on+its+own,+but+are+of+high+priority+for+the+NIH+as+a+whole.”>Google Scholar

Office of the Director, “Science Education,” available at <https://www.nih.gov/research-training/science-education> (last visited March 11, 2020).+(last+visited+March+11,+2020).>Google Scholar

The Health Scientific Interest Group includes research resources for NIH and non-NIH scientists, available at <https://www.nih.gov/research-training/research-resources> (last visited April 16, 2019).+(last+visited+April+16,+2019).>Google Scholar

There are citizen science educational and collaborative projects throughout NIH. The Citizen Science Working Group is a trans-NIH collaboration. See <https://dpcpsi.nih.gov/sites/default/files/Citizen_Science_presentation_to_CoC_Jan31.pdf> (2014) (last visited April 16, 2019).+(2014)+(last+visited+April+16,+2019).>Google Scholar

Addressing ELS Issues in Unregulated Health Research Using Mobile Devices, Mark A. Rothstein and John T. Wil-banks, PIs, No. 1R01CA207538-01A1, National Cancer Institute, National Human Genome Research Institute, and Office of Science Policy and Office of Behavioral and Social Science Research, Office of the Director.Google Scholar

See, e.g., ReCODE Health Tools, Digital Health Decision-Making Framework and Checklist Designed for Researchers, available at <https://recode.health/tools/> (last visited March 11, 2020) (provides information to researchers and other stakeholders interested in safe and responsible digital health research).+(last+visited+March+11,+2020)+(provides+information+to+researchers+and+other+stakeholders+interested+in+safe+and+responsible+digital+health+research).>Google Scholar

Gostin, L.O. and Wiley, L.F., Public Health Law: Power, Duty, Restraint, 3d ed. (Berkeley: University of California Press, 2016): at 116-119.CrossRefGoogle Scholar

21 C.F.R. Part 50.Google Scholar

Id.Google Scholar

Id., at pt. 56.Google Scholar

Id., at pt. 54.Google Scholar

21 U.S.C. §§ 301-399i.Google Scholar

See 21 U.S.C. § 321(h) (codifying § 201(h) of the Food, Drug, and Cosmetic Act, which defines the medical devices that Congress has authorized FDA to regulate).Google Scholar

House Committee on Small Business, Subcommittee on Health and Technology, Mobile Medical App Entrepreneurs: Changing the Face of Health Care, June 27, 2013, available at <https://www.himss.org/us-house-representatives-subcommittee-small-business-health-and-technology-hearing-mobile-medical> (last visited March 11, 2020); Letter from Representative Marsha Blackburn, et al. to Margaret Hamburg, FDA Commissioner, and Julius Genachowski, FCC Chair, April 3, 2012, available at <http://blackburn.house.gov/uploadedfiles/letter_from_congress_to_fda_and_fcc_-_3apr2012.pdf> (last visited March 11, 2020). See generally Sharkey, C.M., “Direct-to-Consumer Genetic Testing: The FDA’s Dual Role as Safety and Health Information Regulator,” DePaul Law Review 68, no. 2 (2019): 343-384 (discussing FDA’s changing role in regulating new technologies).Google Scholar

Food and Drug Administration, Device Software Functions Including Mobile Medical Applications (Sept. 26, 2019), available at <https://www.fda.gov/medical-devices/digital-health/mobile-medical-applications> (last visited March 11, 2020).+(last+visited+March+11,+2020).>Google Scholar

Pub. L. 114-255 (2016).Google Scholar

See 21 U.S.C. § 360j(o)(1) (excluding five categories of software from the definition of a medical device).Google Scholar

Id. at § 360j(o)(1)(B)Google Scholar

Food and Drug Administration, “General Wellness: Policy for Low Risk Devices: Guidance for Industry and Food and Drug Administration Staff (September 27, 2019),” available at <https://www.fda.gov/regulatory-information/search-fda-guidance-documents/general-wellness-policy-low-risk-devices> (last visited Marc 11, 2020).+(last+visited+Marc+11,+2020).>Google Scholar

“Statement from FDA Commissioner Scott Gottlieb, M.D., and Center for Devices and Radiological Health Director Jeff Shuren, M.D., J.D., on Agency Efforts to Work with Tech Industry to Spur Innovation in Digital Health,” available at <https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-and-center-devices-and-radiological-health-director> (last visited March 11, 2020); Food and Drug Administration, “Digital Health Innovation Action Plan,” available at <https://www.fda.gov/media/106331/download> (last visited March 11, 2020).+(last+visited+March+11,+2020);+Food+and+Drug+Administration,+“Digital+Health+Innovation+Action+Plan,”+available+at++(last+visited+March+11,+2020).>Google Scholar

Pub. L. 112-144 (2012).CrossRefGoogle Scholar

Food and Drug Administration, “FDASIA Health IT Report: Proposed Strategy and Recommendations for a Risk-Based Framework,” available at <https://www.fda.gov/media/87886/download> (last visited March 11, 2020).+(last+visited+March+11,+2020).>Google Scholar

Federal Trade Commission, Mobile Health Apps Interactive Tool, available at <https://www.ftc.gov/tips-advice/business-center/guidance/mobile-health-apps-interactive-tool> (last visited March 11, 2020).+(last+visited+March+11,+2020).>Google Scholar

21 U.S.C. § 321(h).Google Scholar

21 C.F.R. § 801.4.Google Scholar

Id.Google Scholar

Id.Google Scholar

Hutt, P.B., Merrill, R.A., and Grossman, L.A., Food and Drug Law 92 (4th ed. 2014).Google Scholar

Id., at 96.Google Scholar

See United States v. Travia, 180 F. Supp. 2d 115 (D.D.C. 2001) (providing one of the rare examples in which FDA successfully relied on circumstantial evidence to establish the intended use of a product—a drug—in a case with highly unusual facts that limit its precedential value).Google Scholar

See FDA General Wellness, supra note 231, at 3-4 (providing examples of claims that would make a device be a medical device, as opposed to a general wellness device).Google Scholar

Id., at pt. 812.Google Scholar

Id. § 812.2(a).Google Scholar

Henley, L., “Clinical Investigator Training Course: How to Put Together an IDE Application,” Food and Drug Administration 17 (November 14, 2013), available at <https://www.fda.gov/media/87607/download> (last visited March 11, 2020).Google Scholar

Medical Devices; Procedures for Investigational Device Exemptions, Federal Register 45: at 3735.Google Scholar

Id.Google Scholar

Id., at 3738.Google Scholar

21 U.S.C. § 396.Google Scholar

See 21 C.F.R. § 812.7(a).Google Scholar

Id. § 812.7(d).Google Scholar

“Lepay: FDA to Take Closer Look at Investigator-Initiated Trial,” Guide to Good Clinical Practice Newsletter 12, no. 4, January 2008, at 1.Google Scholar

See Henley, supra note 246, at 12, 17.Google Scholar

Evans, B.J., “The Limits of FDA’s Authority to Regulate Clinical Research Involving High-Throughput DNA Sequencing,” Food & Drug Law Journal 70, no. 2 (2015): 259-ii.Google Scholar

But cf. Terry, N.P., “Assessing the Thin Regulation of Consumer-Facing Health Technologies,” Journal of Law, Medicine & Ethics 48, no. 1, Suppl. (2020): 94-102 (noting problems of limited coverage and weak protections).CrossRefGoogle Scholar

Hoofnagle, C.J., Federal Trade Commission: Privacy Law and Policy (Cambridge: Cambridge University Press, 2016).CrossRefGoogle Scholar

For a further discussion of these enforcement actions, see Wagner, J., “The Federal Trade Commission and Consumer Protection for Mobile Health Apps,” Journal of Law, Medicine & Ethics 48, no. 1, Suppl. (2020): 103-114.CrossRefGoogle Scholar

Id.Google Scholar

Federal Trade Commission, “Developing a Mobile Health App?” available at <https://www.ftc.gov/tips-advice/business-center/guidance/mobile-health-apps-interactive-tool> (last visited March 11, 2020).+(last+visited+March+11,+2020).>Google Scholar

Consumer Product Safety Commission, Statement of Commissioner Elliot F. Kaye Regarding a Framework of Safety for the Internet of Things, January 31, 2019, available at <https://www.cpsc.gov/s3fs-public/A_Framework_for_Safety_Across_the_Internet_of_Things_1-31-2019_0.pdf?1KJ.t4Tn04v9O-tEBr2s0wyLAP.KsuuQ3> (last visited March 11, 2020).+(last+visited+March+11,+2020).>Google Scholar

Glaser, A., “Apple Is a Tech Regulator,” Slate, June 3, 2019, available at <https://slate.com/technology/2019/06/apple-wwdc-sign-in-facebook-google.html?via=homepage_section_features> (last visited March 11, 2020).+(last+visited+March+11,+2020).>Google Scholar

Wilbanks, J., “Design Issues in E-Consent,” Journal of Law, Medicine & Ethics 46, no. 1 (2018): 1-18.CrossRefGoogle Scholar

Duhaime-Ross, A., “Apple Makes Ethics Board Approval Mandatory for All Medical Research Apps,” The Verge, April 29, 2015, available at <https://www.theverge.com/2015/4/29/8513367/apple-research-kit-ethics-board-mandatory-clinical-trial> (last visited March 11, 2020).+(last+visited+March+11,+2020).>Google Scholar

Srnicek, N., Platform Capitalism (Cambridge, UK: Polity Press, 2017).Google Scholar

Parker, G.G. and Van Alstyne, M.W., “Two-Sided Network Effects: A Theory of Information Product Design,” Management Science 51, no. 10 (2005): 1494-1504.CrossRefGoogle Scholar

See Wiggins and Wilbanks, supra note 5.Google Scholar

Greene, D. and Shilton, K., “Platform Privacies: Governance, Collaboration, and the Different Meanings of ‘Privacy’ in iOS and Android Development,” New Media & Society 20, no. 4 (2018): 1640-1657, available at <https://doi.org/10.1177/1461444817702397> (last visited March 11, 2020).CrossRefGoogle Scholar

Rajasegaran, J. et al., “A Multi-modal Neural Embeddings Approach for Detecting Mobile Counterfeit Apps,” in Liu, L. and White, R., eds., The World Wide Web Conference (WWW ‘19) (New York, NY: ACM, 2019): at 3165-3171, available at <https://doi.org/10.1145/3308558.3313427> (last visited March 11, 2020).CrossRefGoogle Scholar

Andow, B. et al., A Study of Grayware on Google Play. 2016 IEEE Security and Privacy Workshops (SPW) (2016), available at <https://ieeexplore.ieee.org/document/7527773> (last visited March 11, 2020).CrossRef+(last+visited+March+11,+2020).>Google Scholar

Wander, A. et al., “Energy Analysis of Public-Key Cryptography for Wireless Sensor Networks,” in Third IEEE International Conference on Pervasive Computing and Communications (IEEE): 324-328).Google Scholar

Afonin, O., “Smartphone Encryption: Why Only 10 Per Cent of Android Smartphones Are Encrypted,” Elcom Soft Blog, March 21, 2016, available at <https://blog.elcomsoft.com/2016/03/smartphone-encryption-why-only-10-per-cent-of-androidsmartphones-are-encrypted/> (last visited March 11, 2020).+(last+visited+March+11,+2020).>Google Scholar

Porter, J., “Google Wants to Bring Encryption to All with Adiantum,” The Verge, February 11, 2019, available at <https://www.theverge.com/2019/2/11/18220019/google-adiantum-storage-encryption-android-low-power-cheap-cost> (last visited March 11, 2020).+(last+visited+March+11,+2020).>Google Scholar

Cyr, B. et al., “Security Analysis of Wearable Fitness Devices (Fitbit),” Massachusetts Institute of Technology (2014).Google Scholar

This is an effect in which data from a variety of sources, each of which is insufficient to reidentify someone, becomes reidentifiable when assembled or aggregated. See Kugler, M.B. and Strahilevitz, L.J., “Actual Expectations of Privacy, Fourth Amendment Doctrine, and the Mosaic Theory,” Supreme Court Review 2015 (2015): 205-263.CrossRefGoogle Scholar

Copp, T., “Fitness and Fitness Tracking Devices Banned for Deployed Troops,” Military Times, August 6, 2018, available at <https://www.militarytimes.com/news/your-military/2018/08/06/devices-and-apps-that-rely-on-geolocation-restricted-for-deployed-troops/> (last visited March 11, 2020).+(last+visited+March+11,+2020).>Google Scholar

Wischhover, C., “A Life Insurance Company Wants to Track Your Fitness Data,” Vox, September 20, 2018, available at <https://www.vox.com/the-goods/2018/9/20/17883720/fitbit-john-hancock-interactive-life-insurance> (last visited March 11, 2020).+(last+visited+March+11,+2020).>Google Scholar

Na, L. et al., “Feasibility of Reidentifying Individuals in Large National Physical Activity Data Sets from Which Protected Health Information Has Been Removed with Use of Machine Learning,” JAMA Network Open, published online, December 21, 2018, available at <https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2719130> (last visited March 11, 2020).+(last+visited+March+11,+2020).>Google Scholar

Foschini, L., “The Risk of Re-Identification of Wearable Data Is Real (And Well Known),” Medium, February 5, 2001, available at <https://medium.com/@lucafoschini/https-medium-com-lucafoschini-privacy-of-wearables-data-partii-116fec6fbcf> (last visited March 11, 2020).+(last+visited+March+11,+2020).>Google Scholar

Vayena, E. and Tasioulas, J., “Adapting Standards: Ethical Oversight of Participant-Led Health Research,” PLoS Medicine 10, no. 3 (2013): e1001402, available at <https://doi.org/10.1371/journal.pmed.1001402> (last visited March 11, 2020).CrossRefGoogle Scholar

Such a provision could be implemented by reference to a neutral standard’s group’s code of conduct. See, e.g., CARIN Alliance Code of Conduct, available at <https://www.carinalliance.com/our-work/trust-framework-and-code-of-conduct/> (last visited March 11, 2020).+(last+visited+March+11,+2020).>Google Scholar

These notices have been referred to as “nutrition labels.” See Ciochetti, C., “The Future of Privacy Policies: A Privacy Nutrition Label Filled with Fair Information Practices,” John Marshall Journal of Computer and Information Law 26, no. 1 (2009): 1-46; Kelley, P.G. et al., “Standardizing Privacy Notices: An Online Study of the Nutrition Label Approach,” Proceedings of the SIGCHI Conference on Human factors in Computing Systems (2010): 1573-1582, available at <https://dl.acm.org/citation.cfm?id=1753561> (last visited March 11, 2020).Google Scholar

See Anaya, L.H.S. et al., “Ethical Implications of User Perceptions of Wearable Devices,” Science and Engineering Ethics 24, no. 1 (2018): 1-28; Tahir, H., Tahir, R., and McDonald-Maier, K., “On the Security of Consumer Wearable Devices in the Internet of Things,” PLos One (2018), available at <https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0195487> (last visited March 11, 2020).CrossRefGoogle Scholar

Wooley et al., supra note 4; McGowan et al., supra note 6.Google Scholar

McGowan et al., supra note 6.Google Scholar

Bonney, R. et al., “Next Steps for Citizen Science,” Science 2014, no. 343 (2014): 1436; Irwin, A., “Science, Public Engagement,” in Wright, J.D., ed., International Encyclopedia of the Social and Behavioral Sciences (Oxford: Elsevier, 2015): at 255-260.CrossRefGoogle Scholar

Prainsack, B., “Understanding Participation: The ‘Citizen Science’ of Genetics,” in Prainsack, B. et al., eds., Genetics as Social Practice (Farnham, UK: Ashgate, 2014): at 147-164.Google Scholar

McGowan et al., supra note 6.Google Scholar

Id.Google Scholar

Wooley et al., supra note 4.Google Scholar

DIY Bio, Draft DIY Bio Code of Ethics from North American Congress (2011), available at <https://diybio.org/codes/code-of-ethics-north-america-congress-2011/> (last visited March 11, 2020).+(last+visited+March+11,+2020).>Google Scholar